Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
136.8 EUR | +0.41% | -1.39% | -3.80% |
03:23pm | Johnson & Johnson's Balversa Gets EU Panel Recommendation for Urothelial Carcinoma | MT |
08:00am | Dealmakers optimistic on global M&A prospects despite sluggish growth | RE |
Official Publications
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-1 | CO | |
Shareholders meeting voting results | CO | |
SEC Filing 8K | CO | |
Slide show Q1 | CO | |
1st quarter results | CO | |
SEC Filing 13G | CO | |
Proxy Statments | CO | |
SEC Filing 10K | CO | |
SEC Filing 13G | CO | |
SEC Filing 8K | CO | |
Slide show results | CO | |
Annual results | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-3 | CO | |
SEC Filing 8K | CO | |
Slide show Q3 | CO | |
3rd quarter results | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO |
- Stock Market
- Equities
- JNJ Stock
- JNJ Stock
- News Johnson & Johnson
- Official Publications